top of page
Tangible Value

From Niche to Notable: Scaling Silene Biotech to Acquisition
The leadership team behind AcquireNow previously led Silene Biotech from a niche DTC stem-cell concept to a marketable service embraced by early adopters, expanded to physician-guided baby boomers, and ultimately achieved acquisition by CuriBio.
80%
Opt‑In Rate Doubled to 80%​
2K
2,000 Customers & $1.1M in Revenue​
10%
Sustained 10% Month‑Over‑Month Growth
Case Studies

Let’s Build Your Growth Strategy!
Thank you! We'll be in touch within 24 hours.
bottom of page